Glycosyl compounds
Medchemexpress LLC PGLYRP4/PGRP-I beta 10ug | 10ug
PGLYRP4/PGRP-I beta protein is a model receptor that binds to the cell wall peptide peptidoglycan (PGN) in Gram-positive bacteria and exerts bactericidal activity by interfering with peptidoglycan biosynthesis Its antimicrobial properties extend to Gram-negative bacteria although it also binds to them PGLYRP4/PGRP-I beta Protein Human (HEK293 His) is the recombinant human-derived PGLYRP4/PGRP-I beta protein expressed by HEK293 with C-His labeled tag
Apexbio Technology LLC Anti-Amyloid Beta Solanezumab
Anti-Amyloid Beta Antibody (Solanezumab) (CAS No 955085-14-0) is a monoclonal antibody used in Alzheimer s research originating from Eli Lilly and Company It specifically targets amyloid beta plaques implicated in Alzheimer s pathogenesis by binding to soluble monomers thereby reducing plaque formation Solanezumab s action is primarily observed in the modulation of amyloid beta clearance mechanisms within the central nervous system In vitro activity typically occurs in the nanomolar range reflecting its high affinity and specificity for amyloid beta peptides It s commonly applied in cell models and animal studies to evaluate therapeutic potential particularly in transgenic mice expressing human amyloid precursor protein Additionally Solanezumab is prominent in drug screening processes for Alzheimer s therapeutics Experimental concentrations typically depend on the specific research design ensuring flexibility in dose-response assessments across different methodologies
Apexbio Technology LLC Anti-Amyloid Beta Solanezumab
Anti-Amyloid Beta Antibody (Solanezumab) (CAS No 955085-14-0) is a monoclonal antibody used in Alzheimer s research originating from Eli Lilly and Company It specifically targets amyloid beta plaques implicated in Alzheimer s pathogenesis by binding to soluble monomers thereby reducing plaque formation Solanezumab s action is primarily observed in the modulation of amyloid beta clearance mechanisms within the central nervous system In vitro activity typically occurs in the nanomolar range reflecting its high affinity and specificity for amyloid beta peptides It s commonly applied in cell models and animal studies to evaluate therapeutic potential particularly in transgenic mice expressing human amyloid precursor protein Additionally Solanezumab is prominent in drug screening processes for Alzheimer s therapeutics Experimental concentrations typically depend on the specific research design ensuring flexibility in dose-response assessments across different methodologies
Medchemexpress LLC IL-1 beta Canine T 100ug
IL-1 beta Protein Canine (Tag free) is the recombinant canine-derived IL-1 beta expressed by E coli with tag Free labeled tag
Medchemexpress LLC NRG1-beta 1 Human 10ug
HRG1- 1 belongs to a family of structurally-related polypeptide growth factors derived from alternatively spliced genes induces Fn14 expression in MCF7 cells NRG1-beta 1 Protein Human (245a a HEK293 Fc) is the recombinant human-derived NRG1-beta 1 protein expressed by HEK293 with N-hFc labeled tag
Medchemexpress LLC Interleukin-10 receptor subunit beta, mouse recombinant (HEK293, His-tag) | >98.0% | 500 UG
Recombinant mouse interleukin-10 receptor subunit beta expressed in HEK293 cells and supplied as a C-terminal His-tagged, purified protein for research use. Characterization data such as purity, molecular weight, and formulation are available from the supplier.
Medchemexpress LLC FGFR-1 beta IIIc 100ug | 100ug
FGFR-1 alpha is a tyrosine-protein kinase receptor for fibroblast growth factor that is critical in embryonic development cell proliferation differentiation and migration GnRH is essential for mesodermal patterning axial organization skeletogenesis and nervous system development FGFR-1 beta (IIIc) Protein Human (HEK293 His-Avi) is the recombinant human-derived FGFR-1 beta expressed by HEK293 with C-Avi C-His labeled tag
![eMolecules 69414-26-2 | 4-Methylumbelliferyl-alpha-L-arabinopyranoside | Apollo Scientific | MFCD00064087 | 308.286 | C15H16O7 | 0.000 | Cc1cc(=O)oc2cc(O[C@@H]3OC[C@H](O)[C@H](O)[C@H]3O)ccc12 | 100mg | 562467286](https://assets.fishersci.com/TFS-Assets/CCG/product-images/502151915.JPG-250.jpg)
eMolecules 69414-26-2 | 4-Methylumbelliferyl-alpha-L-arabinopyranoside | Apollo Scientific | MFCD00064087 | 308.286 | C15H16O7 | 0.000 | Cc1cc(=O)oc2cc(O[C@@H]3OC[C@H](O)[C@H](O)[C@H]3O)ccc12 | 100mg | 562467286
4-Methylumbelliferyl-alpha-L-arabinopyranoside | Apollo Scientific | 69414-26-2 | MFCD00064087 | 308.286 | C15H16O7 | 0.000 | Cc1cc(=O)oc2cc(O[C@@H]3OC[C@H](O)[C@H](O)[C@H]3O)ccc12 | 100mg | 562467286
Alkali Scientific 4 Nitrophenyl 2 acetamido 2 deoxy β D glucopyranoside, 1 G
4-Nitrophenyl 2-acetamido-2-deoxy-β-D-glucopyranoside (1g) is a chemical reagent used to investigate β-D-glucosidase and related enzyme activities in carbohydrate biochemistry. The compound, upon cleavage by β-D-glucosidase, releases p-nitrophenol, a product that can be quantified using spectrophotometric methods. This substrate is frequently used in enzyme assays for studying glycoside hydrolases, enzymes that play crucial roles in carbohydrate metabolism and cellular processes such as glycosylation and hydrolysis. The reagent is critical in research on metabolic pathways and the characterization of enzymes involved in sugar processing.